Stem Cell Therapeutics Corp. Announces Completion of Further Analysis of the …
Stem Cell Therapeutics Corp. (”SCT” or the “Company”) (TSX VENTURE: SSS) wishes to announce that further analyses of the modified REGENESIS stroke data base have been completed. First, no dose-related treatment …
[Read the full article here]Related News:
Stem Cell Therapeutics Corp. Announces Completion of Further Analysis of the Modified REGENESIS Stroke Data
Stem Cell Therapeutics Corp. Announces the Completion of the 90 Day Endpoint Period for the Last Patient Enrolled in …
Stem Cell Therapeutics Corp. Announces The Date For The Release Of Top-Line Results In The Modified REGENESIS Phase …